This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care Announces Chief Medical Officer And Appoints New President For The Service Operations In North America

Fresenius Medical Care (NYSE: FMS), the world’s largest provider of dialysis products and services, announced that Franklin W. Maddux, M.D., FACP, has been appointed Chief Medical Officer (CMO) for Fresenius Medical Care North America (FMCNA), effective December 12, 2011. In this role he will also be responsible for Clinical and Scientific Affairs.

Dr. Maddux will report to Rice Powell, Chief Executive Officer of Fresenius Medical Care North America and Deputy Chairman of the Management Board, who commented: “We are very excited to have Frank expand his role with Fresenius Medical Care. Frank has been working for us since 2009 and has an impressive experience in the health-care industry. He is an outstanding choice as his career and research interests have focused on the quality of care for chronic kidney disease patients.”

In his new role, Dr. Maddux will oversee the delivery of quality care to more than 140,000 dialysis patients across the United States, and will direct a number of clinical studies and initiatives programs designed to improve dialysis care in the future.

Dr. Maddux joined FMCNA in 2009 after the company acquired Health IT Services Group, a leading-edge Electronic Health Record software company that he founded in 2007. He has more than 25 years of experience in the health-care industry, including the practice of nephrology. Dr. Maddux also serves as Clinical Associate Professor of Medicine at the University of North Carolina School Of Medicine. He has served on numerous boards and committees involved in developing technology initiatives in both the medical and regional economic development arenas. Dr. Maddux received his bachelor’s degree in mathematics from Vanderbilt University and an MD degree from the University of North Carolina at Chapel Hill.

Dr. Maddux replaces Dr. Raymond Hakim, a true leader in the dialysis industry who helped FMCNA place a sharp focus on the highest quality patient care.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs